Vile R - Search Results

1

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.

Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R, Melcher A, Prestwich R, Harrington KJ, Morgan R, Pandha HS. Heinemann L, et al. Among authors: vile r. BMC Cancer. 2011 Jun 6;11:221. doi: 10.1186/1471-2407-11-221. BMC Cancer. 2011. PMID: 21645351 Free PMC article.

2

A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model.

Castleden SA, Chong H, Garcia-Ribas I, Melcher AA, Hutchinson G, Roberts B, Hart IR, Vile RG. Castleden SA, et al. Among authors: vile rg. Hum Gene Ther. 1997 Nov 20;8(17):2087-102. doi: 10.1089/hum.1997.8.17-2087. Hum Gene Ther. 1997. PMID: 9414257

3

Genetic prodrug activation therapy.

Martin LA, Vile R, Lemoine NR, Sikora K, Pandha HS. Martin LA, et al. Among authors: vile r. Lancet. 1997 Dec 20-27;350(9094):1793-4. doi: 10.1016/s0140-6736(05)63633-1. Lancet. 1997. PMID: 9428248 No abstract available.

4

Gene therapy for cancer--managing expectations.

Melcher AA, Garcia-Ribas I, Vile RG. Melcher AA, et al. Among authors: vile rg. BMJ. 1997 Dec 13;315(7122):1604-7. doi: 10.1136/bmj.315.7122.1604. BMJ. 1997. PMID: 9437283 Free PMC article. Review. No abstract available.

5

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.

Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Melcher A, et al. Among authors: vile rg. Nat Med. 1998 May;4(5):581-7. doi: 10.1038/nm0598-581. Nat Med. 1998. PMID: 9585232

6

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Todryk SM, Chong H, Vile RG, Pandha H, Lemoine NR. Todryk SM, et al. Among authors: vile rg. Gut. 1998 Oct;43(4):445-9. doi: 10.1136/gut.43.4.445. Gut. 1998. PMID: 9824562 Free PMC article.

7

Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectors.

Melcher A, Murphy S, Vile R. Melcher A, et al. Among authors: vile r. Hum Gene Ther. 1999 Jun 10;10(9):1431-42. doi: 10.1089/10430349950017770. Hum Gene Ther. 1999. PMID: 10395369

8

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

Melcher A, Gough M, Todryk S, Vile R. Melcher A, et al. Among authors: vile r. J Mol Med (Berl). 1999 Dec;77(12):824-33. doi: 10.1007/s001099900066. J Mol Med (Berl). 1999. PMID: 10682318 Review.

9

Heat shock proteins refine the danger theory.

Todryk SM, Melcher AA, Dalgleish AG, Vile RG. Todryk SM, et al. Among authors: vile rg. Immunology. 2000 Mar;99(3):334-7. doi: 10.1046/j.1365-2567.2000.00002.x. Immunology. 2000. PMID: 10712661 Free PMC article. No abstract available.

10

Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Stewart JS. Harrington KJ, et al. Among authors: vile rg. Clin Cancer Res. 2000 Jun;6(6):2528-37. Clin Cancer Res. 2000. PMID: 10873109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters